Mon, July 2, 2018
Fri, June 29, 2018
Thu, June 28, 2018
Wed, June 27, 2018
Tue, June 26, 2018
Mon, June 25, 2018
Fri, June 22, 2018
Thu, June 21, 2018
Wed, June 20, 2018
Tue, June 19, 2018
Mon, June 18, 2018
Fri, June 15, 2018
Thu, June 14, 2018
Wed, June 13, 2018
Tue, June 12, 2018
Mon, June 11, 2018
Fri, June 8, 2018
Thu, June 7, 2018
Wed, June 6, 2018
Tue, June 5, 2018

Josh Schimmer Upgraded (BLUE) to Buy and Increased Target to $230 on, Jun 19th, 2018

  Copy link into your clipboard //stocks-investing.news-articles.net/content/201 .. nd-increased-target-to-230-on-jun-19th-2018.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication


Josh Schimmer of Evercore ISI Group, Upgraded "bluebird bio, Inc." (BLUE) to Buy and Increased Target from $175 to $230 on, Jun 19th, 2018.

Josh has made no other calls on BLUE in the last 4 months.



There are 3 other peers that have a rating on BLUE. Out of the 3 peers that are also analyzing BLUE, 2 agree with Josh's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Matthew Harrison of "Morgan Stanley" Maintained at Hold with Increased Target to $209 on, Wednesday, March 21st, 2018
  • Ying Huang of "B of A Securities" Maintained at Hold with Increased Target to $218 on, Thursday, February 22nd, 2018


This is the rating of the analyst that currently disagrees with Josh


  • Matthew Luchini of "BMO Capital" Maintained at Buy with Decreased Target to $216 on, Thursday, May 3rd, 2018